SurfKY News

FDA Approves Drug Formulated for Kids with Rare Brain Tumors
SurfKY News
Afinitor Disperz is recommended to treat patients ages 1 year and older with tuberous sclerosis complex (TSC) who are diagnosed with SEGA that cannot be treated with surgery. Prior to approval of this new dosage form, Afinitor was recommended for use ...
FDA Approves Novartis Tumor Drug for ChildrenFox Business
Afinitor Disperz Approved for Rare Pediatric CancerU.S. News & World Report
FDA approves first pediatric dosage for rare brain tumorMedCity News

all 32 news articles »


More...